Aug 21 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- FY REPORTED REVENUES OF $457.0M, DOWN 13% ON FY19
- FY REPORTED EBITDA OF $80.3M, DOWN 28%
- FY UNDERLYING EBITDA OF $95.3M, DOWN 27%
Aug 21 (Reuters) - Mayne Pharma Group Ltd (MYX) : FY REPORTED...
Add to My Watchlist
What is My Watchlist?